Caring Brands (CABR) Q4 2025 earnings summary

Executive summary

• Wellness consumer products company focused on OTC and cosmetic products for hair loss, eczema, psoriasis, vitiligo, and suncare, with a pipeline supported by clinical trials and patent protection.

• Completed IPO in November 2025, raising $4M gross ($3.24M net), with cash and equivalents of $2.19M at year-end.

• Minimal revenues ($4,215 in 2025), net loss of $6.28M in 2025, and accumulated deficit of $7.14M.

• Significant impairment charges on intellectual property ($2.55M) and investment ($0.5M) in 2025.

Financial highlights

• Revenue: $4,215 in 2025, up from $465 in 2024.

• Operating expenses: $5.94M in 2025, up from $1.53M in 2024, driven by payroll, professional fees, and IP amortization.

• Net loss: $6.28M in 2025 vs. $1.52M in 2024.

• Cash used in operations: $1.69M in 2025.

• Cash provided by financing: $3.41M in 2025, mainly from IPO and debt.

• Total assets: $2.33M at 2025 year-end, down from $3.88M in 2024 due to impairments.

• Total liabilities: $235K at 2025 year-end.

Outlook and guidance

• Management believes current cash is sufficient for at least 12 months but may seek additional capital for growth.

• Focus on expanding e-commerce, refining marketing, and launching new products, including reformulated eczema and suncare lines.

• Exploring acquisition opportunities in OTC/cosmetic therapeutic brands.